Goldman Sachs’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,788
Closed -$105K 5921
2018
Q3
$105K Buy
+12,788
New +$96.1K ﹤0.01% 5124
2016
Q4
Sell
-11,209
Closed -$126K 7215
2016
Q3
$126K Buy
11,209
+707
+7% +$9.09K ﹤0.01% 6110
2016
Q2
$151K Buy
+10,502
New +$136K ﹤0.01% 5889
2014
Q4
Sell
-3,539
Closed -$83K 7429
2014
Q3
$83K Buy
+3,539
New +$81.5K ﹤0.01% 6661
2014
Q2
Sell
-2,660
Closed -$76K 7235
2014
Q1
$76K Buy
+2,660
New +$81.9K ﹤0.01% 6478
2013
Q3
Sell
-3,512
Closed -$73K 6780
2013
Q2
$73K Buy
+3,512
New +$46.5K ﹤0.01% 5960

Other funds holding HQCL

Goldman Sachs's HQCL Position: Q4 2018 in Review

Goldman Sachs sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q4 2018, closing a stake of 12,788 shares — an estimated $105K sold.

Goldman Sachs first reported a position in HQCL in Q2 2013 and held it in 6 quarters. The position peaked at $151K in Q2 2016. 18 funds tracked by Wall St. Rank hold HQCL as of Q4 2018.

  • Goldman Sachs reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q4 2018 after selling out during the quarter.
  • Goldman Sachs sold 12,788 Hanwha Q CELLS Co., Ltd. shares in Q4 2018, an estimated $105K.
  • Goldman Sachs first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2013 and held it in 6 quarters.
  • Goldman Sachs's Hanwha Q CELLS Co., Ltd. position peaked at $151K in Q2 2016.
  • 18 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q4 2018.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.